東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Gene therapy and cell therapy throug...

Terai, Shuji.

FindBook

Google Book

Amazon

博客來

Gene therapy and cell therapy through the liver = current aspects and future prospects /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Gene therapy and cell therapy through the liver/ edited by Shuji Terai, Takeshi Suda.
其他題名:	current aspects and future prospects /
其他作者:	Terai, Shuji.
出版者:	Tokyo :Springer Japan : : 2016.,
面頁冊數:	x, 185 p. :ill., digital ;24 cm.
內容註:	1. Liver-Targeted Gene and Cell Therapies: An Overview -- Part I. Cell Therapy -- 2. Macrophage Therapy for Liver Fibrosis and Regeneration -- 3. Liver Regeneration Therapy Using Autologous Bone Marrow-Derived Cells for Cirrhotic Patients -- 4. Novel Immunotherapy Using Liver Natural Killer Cells for Preventing Recurrence of Hepatocellular Carcinoma in Liver Transplantation -- 5. Cell-Based Immunotherapy for HCC: Our Experiences and Future Directions -- Part II. Gene Therapy -- 6. AAV Vector-Mediated Liver Gene Therapy and Its Implementation for Hemophilia -- 7. Potential Usage of Human Artificial Chromosome for Regenerative Medicine -- 8. Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applications -- Part III. Legal Regulation 9. The Way to Clinical Applications of Human Pluripotent Stem Cells -- 10. Regulation for Gene and Cell Therapy Medicinal Products in Europe -- 11. IPSC-Derived Products: Current Regulations -- 12. Critical Path Initiative for Regenerative Medicine in Japan -- 13. Aseptic Manufacturing of Regenerative Medicine Products Using Isolator Technology -- 14. Cell and Vector Production Facility for Gene Therapy and Cell Therapy.
Contained By:	Springer eBooks
標題:	Liver - Diseases -
電子資源:	http://dx.doi.org/10.1007/978-4-431-55666-4
ISBN:	9784431556664$q(electronic bk.)

Gene therapy and cell therapy through the liver = current aspects and future prospects /
Gene therapy and cell therapy through the livercurrent aspects and future prospects /[electronic resource] :edited by Shuji Terai, Takeshi Suda. - Tokyo :Springer Japan :2016. - x, 185 p. :ill., digital ;24 cm.

1. Liver-Targeted Gene and Cell Therapies: An Overview -- Part I. Cell Therapy -- 2. Macrophage Therapy for Liver Fibrosis and Regeneration -- 3. Liver Regeneration Therapy Using Autologous Bone Marrow-Derived Cells for Cirrhotic Patients -- 4. Novel Immunotherapy Using Liver Natural Killer Cells for Preventing Recurrence of Hepatocellular Carcinoma in Liver Transplantation -- 5. Cell-Based Immunotherapy for HCC: Our Experiences and Future Directions -- Part II. Gene Therapy -- 6. AAV Vector-Mediated Liver Gene Therapy and Its Implementation for Hemophilia -- 7. Potential Usage of Human Artificial Chromosome for Regenerative Medicine -- 8. Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applications -- Part III. Legal Regulation 9. The Way to Clinical Applications of Human Pluripotent Stem Cells -- 10. Regulation for Gene and Cell Therapy Medicinal Products in Europe -- 11. IPSC-Derived Products: Current Regulations -- 12. Critical Path Initiative for Regenerative Medicine in Japan -- 13. Aseptic Manufacturing of Regenerative Medicine Products Using Isolator Technology -- 14. Cell and Vector Production Facility for Gene Therapy and Cell Therapy.

This book reports the recent progress in gene and cell therapy through the liver and aims to facilitate a comprehensive understanding of the current aspects and future prospects from basic research to clinical therapies. Edited by pioneering researchers, this volume presents extensive information to principal investigators, researchers, postdocs, and clinicians for examining the wide varieties of pathological conditions both inside and outside the liver. Providing not only the basic and clinical aspects of therapy, this volume is special in that it focuses on the administrative and regulatory difficulties of actual clinical application and legal regulations in different parts of the globe. By indicating the advantages and limitations of the most promising gene and cell therapies targeting the liver, this book will inspire readers to develop a feasible treatment in the next generation.

ISBN: 9784431556664$q(electronic bk.)

Standard No.: 10.1007/978-4-431-55666-4doiSubjects--Topical Terms:

2180436
Liver
--Diseases

LC Class. No.: RC846

Dewey Class. No.: 616.3620695

Gene therapy and cell therapy through the liver = current aspects and future prospects /
LDR:03050nmm a2200313 a 4500 001 2029427
003 DE-He213
005 20160727151650.0
006 m d
007 cr nn 008maaau
008 160908s2016 ja s 0 eng d
020 $a 9784431556664$q(electronic bk.)
020 $a 9784431556657$q(paper)
024 7 $a 10.1007/978-4-431-55666-4 $2 doi
035 $a 978-4-431-55666-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC846
072 7 $a MJJ $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.3620695 $2 23
090 $a RC846 $b .G326 2016
245 0 0 $a Gene therapy and cell therapy through the liver $h [electronic resource] : $b current aspects and future prospects / $c edited by Shuji Terai, Takeshi Suda.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a x, 185 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Liver-Targeted Gene and Cell Therapies: An Overview -- Part I. Cell Therapy -- 2. Macrophage Therapy for Liver Fibrosis and Regeneration -- 3. Liver Regeneration Therapy Using Autologous Bone Marrow-Derived Cells for Cirrhotic Patients -- 4. Novel Immunotherapy Using Liver Natural Killer Cells for Preventing Recurrence of Hepatocellular Carcinoma in Liver Transplantation -- 5. Cell-Based Immunotherapy for HCC: Our Experiences and Future Directions -- Part II. Gene Therapy -- 6. AAV Vector-Mediated Liver Gene Therapy and Its Implementation for Hemophilia -- 7. Potential Usage of Human Artificial Chromosome for Regenerative Medicine -- 8. Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applications -- Part III. Legal Regulation 9. The Way to Clinical Applications of Human Pluripotent Stem Cells -- 10. Regulation for Gene and Cell Therapy Medicinal Products in Europe -- 11. IPSC-Derived Products: Current Regulations -- 12. Critical Path Initiative for Regenerative Medicine in Japan -- 13. Aseptic Manufacturing of Regenerative Medicine Products Using Isolator Technology -- 14. Cell and Vector Production Facility for Gene Therapy and Cell Therapy.
520 $a This book reports the recent progress in gene and cell therapy through the liver and aims to facilitate a comprehensive understanding of the current aspects and future prospects from basic research to clinical therapies. Edited by pioneering researchers, this volume presents extensive information to principal investigators, researchers, postdocs, and clinicians for examining the wide varieties of pathological conditions both inside and outside the liver. Providing not only the basic and clinical aspects of therapy, this volume is special in that it focuses on the administrative and regulatory difficulties of actual clinical application and legal regulations in different parts of the globe. By indicating the advantages and limitations of the most promising gene and cell therapies targeting the liver, this book will inspire readers to develop a feasible treatment in the next generation.
650 0 $a Liver $x Diseases $x Gene therapy. $3 2180436
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Hepatology. $3 894467
650 2 4 $a Gene Therapy. $3 600618
650 2 4 $a Gastroenterology. $3 828956
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 2055677
650 2 4 $a Internal Medicine. $3 858559
700 1 $a Terai, Shuji. $3 2180434
700 1 $a Suda, Takeshi. $3 2180435
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55666-4
950 $a Medicine (Springer-11650)